-
Lowering age to 18 years for vaccination is decisive step to restore confidence: Assocham
Speedier the vaccination and reduction in COVID 19 cases, faster would be economic recovery and safeguarding of livelihood concerns, Assocham said
-
India can scale vaccination for up to 5-10 million people: Nandan Nilekani
India can scale up its COVID-19 vaccination efforts to inoculate 5-10 million people a day by adopting a streamlined approach using technology, Nandan
-
Delhi records 16,699 new COVID-19 cases, 112 deaths; positivity rate over 20% now
As per the latest bulletin, 16,699 fresh cases and 112 new fatalities were recorded in the city, pushing the death toll to 11,652
-
Google pledges funds towards vaccine delivery in low, middle income countries
Google pledged funds for 250,000 COVID-19 vaccinations and technical assistance towards vaccine delivery in low- and middle-income countries amidst a
-
Mumbai reports 9,925 new COVID-19 cases, 54 more deaths
The daily case tally shot up in the financial capital after remaining below 8,000 for the last two days
-
Dr Reddy’s working on stability data on 2 to 8 degree temperature range for Sputnik V
The vaccine will be imported in a frozen condition from Russian Direct Investment Fund (RDIF) with which it has an agreement to distribute 125 million
-
Delhi records 13,468 COVID-19 cases, highest single-day spike; 81 deaths
The positivity rate rose to 13.14% from 12.44% a day ago. The 81 deaths are the highest since December 3 when 82 fatalities were recorded
-
COVID-19 vaccines are disease-modifying, reduce chances of severe infection: ICMR chief
Covid-19 vaccines are 'disease-modifying' and there is an 85% reduction in hospitalisation after vaccination which is well established internationally
-
HGCO19 vaccine candidate: Gennova starts enrolment for Phase 1/2 human clinical trials
The Department of Biotechnology has approved additional funding towards clinical studies of India's first of its kind' mRNA-based COVID-19 vaccine, HG
-
Centre fast-tracks emergency approval of foreign-produced COVID-19 vaccines
The move will expand the basket of vaccines for domestic use
